A high neutrophil to lymphocyte ratio is associated with refractory Kawasaki disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho, Hong-Je | - |
dc.contributor.author | Bak, So Young | - |
dc.contributor.author | Kim, Su Yeong | - |
dc.contributor.author | Yoo, Rita | - |
dc.contributor.author | Baek, Hae-Sung | - |
dc.contributor.author | Yang, Seung | - |
dc.contributor.author | Hwang, Il-Tae | - |
dc.contributor.author | Ban, Ji-Eun | - |
dc.date.accessioned | 2022-07-14T01:53:50Z | - |
dc.date.available | 2022-07-14T01:53:50Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 1328-8067 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/152163 | - |
dc.description.abstract | Background: The clinical significance of the neutrophil : lymphocyte ratio (NLR) has not yet been fully elucidated in Kawasaki disease (KD). The purpose of this study was to investigate the relationship between NLR and response to i.v. immunoglobulin (IVIG), and its effect on coronary abnormalities in KD. Methods: A total of 196 KD patients treated with IVIG were analyzed. Baseline NLR was evaluated immediately before IVIG therapy and the patients classified into two groups according to NLR. The clinical data, other inflammatory biomarkers, and coronary complications were also assessed. Results: Kawasaki disease patients with NLR ≥ 5 had a greater incidence of IVIG refractoriness than the NLR < 5 group (31.7% vs 4.3%, P < 0.001), but this was not related to the development of coronary abnormalities. The change in NLR after IVIG (i.e. ΔNLR) was significantly decreased in the coronary abnormality group (2.65 ± 1.88 vs 3.81 ± 2.55, P = 0.042). On multivariate analysis, high NLR and CRP were independent predictors of IVIG refractoriness during the acute phase of KD (P = 0.032 in NLR; P = 0.029 in CRP, respectively). Conclusions: High NLR was closely associated with resistance to IVIG, but it was not related to the occurrence of coronary abnormalities in KD. Low ΔNLR after IVIG, however, was significantly associated with coronary artery abnormalities. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | WILEY-BLACKWELL | - |
dc.title | A high neutrophil to lymphocyte ratio is associated with refractory Kawasaki disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yang, Seung | - |
dc.identifier.doi | 10.1111/ped.13240 | - |
dc.identifier.scopusid | 2-s2.0-85017581843 | - |
dc.identifier.wosid | 000403725600003 | - |
dc.identifier.bibliographicCitation | PEDIATRICS INTERNATIONAL, v.59, no.6, pp.669 - 674 | - |
dc.relation.isPartOf | PEDIATRICS INTERNATIONAL | - |
dc.citation.title | PEDIATRICS INTERNATIONAL | - |
dc.citation.volume | 59 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 669 | - |
dc.citation.endPage | 674 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pediatrics | - |
dc.relation.journalWebOfScienceCategory | Pediatrics | - |
dc.subject.keywordPlus | CORONARY-ARTERY ANEURYSMS | - |
dc.subject.keywordPlus | LYMPHOCYTE RATIO | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | POLYMORPHISM | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | PREDICTION | - |
dc.subject.keywordPlus | CHILDREN | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Kawasaki disease | - |
dc.subject.keywordAuthor | neutrophil : lymphocyte ratio | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/ped.13240 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.